Xylem Inc.·4

Feb 12, 2:35 PM ET

CRAWFORD CURTIS J 4

4 · Xylem Inc. · Filed Feb 12, 2018

Insider Transaction Report

Form 4
Period: 2018-02-08
Transactions
  • Exercise/Conversion

    Common Stock

    2018-02-08$30.02/sh+2,860$85,85755,245 total
  • Sale

    Common Stock

    2018-02-08$71.85/sh2,860$205,49152,385 total
  • Sale

    Common Stock

    2018-02-08$71.72/sh5,088$364,91147,297 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-02-082,8600 total
    Exercise: $30.02Exp: 2020-03-05common stock (2,860 underlying)
Footnotes (3)
  • [F1]This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $71.85 to $71.86 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
  • [F2]This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $71.72 to $71.73 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
  • [F3]These options are fully vested and exercisable.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION